Compugen Narrows Loss, Posts $90K in Revenues in Q4 | GenomeWeb
NEW YORK (GenomeWeb News) – Compugen said today that it narrowed its fourth-quarter net loss to $3.1 million from $3.8 million in the fourth quarter of 2006. 
 
The company reported $90,000 in revenues for the quarter ended Dec. 31, 2007, compared to $10,000 for the fourth quarter of 2006. Revenues for both periods are from “small initial milestone payments under earlier agreements,” Compugen said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.